Atlas FDA

Apollo Onyx Delivery Microcatheter

FDA premarket approval P030004/S021 · decided 2019-12-10

Approval details

PMA number
P030004
Supplement
S021
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Apollo Onyx Delivery Microcatheter
Generic name
Agent, injectable, embolic
Applicant
Ev3 Neurovascular
Date received
2019-08-21
Decision date
2019-12-10
Days to decision
111 days
Decision code
APPR
Product code
MFE
Advisory committee
Neurology
Expedited review
No
Location
Irvine, CA
Statement
Approval for a manufacturing site located at Medtronic Distribution Center, 4340 Swinnea Road, Memphis, Tennessee 38118, for the repackaging of the Apollo Onyx Delivery Microcatheter and Pipeline Flex Embolization Device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MERIDIAN GUIDEWIRE (K093681)Ev3 Neurovascular2010-01-26
HYPERGLIDE OCCLUSION BALLOON SYSTEM, HYPERFORM OCCLUSION BALLOON SYSTEM, MODEL 104-4112, 104-4113, 104-4127,104-4132,104 (K091458)Ev3 Neurovascular2009-10-15
HYPERGLIDE OCCLUSION BALLOON SYSTEM, MODEL 104-4310, 104-4315 (K092495)Ev3 Neurovascular2009-09-22